Fresh2 Group Ltd., formerly known as AnPac Bio-Medical Science Co., Ltd., will undergo a ticker symbol change on the Nasdaq Stock Market. The change will be effective on May 22, 2023, coinciding with the company's name change. The ticker symbol will change from "ANPC" to "FRES". This change reflects the company's new brand identity in the U.S. food market as they enter the business-to-business e-commerce food platform sector.
Mr. Haohan Xu, Co-CEO of Fresh2 Group Ltd., expressed that the ticker symbol change is part of the company's strategic initiative to focus on their new business line of business-to-business food trade and delivery platform. He believes that the change aligns with their vision for the future and will help increase their presence in the new business sector.
No action is required by the company's shareholders regarding the ticker symbol change. The company's CUSIP number will remain unchanged.
Fresh2 Group Limited is a biotechnology company that specializes in early cancer screening and detection. They have multiple certified clinical laboratories in China and the United States. In addition to their cancer screening and detection tests, the company is expanding into the business-to-business e-commerce food business through the formation of their subsidiary, Fresh2 Technology Inc., and the acquisition of Fresh2 Ecommerce Inc.
For more information, please visit: https://fresh2.co/investors.
For investor and media inquiries, please contact Ascent Investor Relations LLC: Tina Xiao, Phone: +1-917-609-0333 (U.S.), Email: firstname.lastname@example.org
This announcement contains forward-looking statements regarding Fresh2 Group Ltd.'s future financial and operating performance. These statements are made under the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. The company has attempted to identify forward-looking statements through various terminologies. However, these statements are based on current expectations, assumptions, and uncertainties, making them difficult to predict accurately. The company acknowledges that there are known and unknown risks, uncertainties, and other factors that may cause the actual results to be materially different from the forward-looking statements. These risks include compliance with Nasdaq Listing Rules, market conditions, business development, intellectual property protections, regulatory approvals, economic conditions, and the impact of the COVID-19 virus. The company advises against placing undue reliance on these forward-looking statements and will not revise or update them publicly unless required by law.
SOURCE: Fresh2 Group Limited